Who owns KINNATE BIOPHARMA INC?
- Ticker: KNTE
- CUSIP Number: 49705r105
Tip: Access positions for across all investors
Analyze quarterly positions in Kinnate Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv

Top investors of Kinnate Biopharma stock
Who bought or sold KINNATE BIOPHARMA INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | ||
---|---|---|---|---|---|---|
Foresite Capital Management IV | 9.7M | $385M | 100% | Dec 2020 | ||
OrbiMed Advisors | 3.8M | $153M | 100% | Dec 2020 | ||
RA Capital Management | 3.6M | $143M | 100% | Dec 2020 | ||
Vida Ventures Advisors | 2.7M | $109M | 100% | Dec 2020 | ||
FMR | 2.5M | $94M | 100% | Dec 2020 | ||
Viking Global Investors | 1.9M | $75M | 100% | Dec 2020 | ||
VR Adviser | 1.5M | $59M | 100% | Dec 2020 | ||
Citadel Advisors | 1.3M | $52M | 100% | Dec 2020 | ||
Boxer Capital | 1.1M | $42M | 100% | Dec 2020 | ||
Foresite Capital Management V | 875k | $35M | 100% | Dec 2020 | ||
Vanguard Group | 852k | $33M | 100% | Dec 2020 | ||
Setup an alertWant to be notified whenever an investor makes a significant change to their holdings of Kinnate Biopharma? |
||||||
Henderson Group | 806k | $30M | 100% | Dec 2020 | ||
T. Rowe Price Associates | 649k | $26M | 100% | Dec 2020 | ||
Logos Global Management | 570k | $23M | 100% | Dec 2020 | ||
Harvard Management Company | 498k | $20M | 100% | Dec 2020 | ||
Deerfield Management Company | 345k | $14M | 100% | Dec 2020 | ||
Partner Fund Management | 342k | $14M | 100% | Dec 2020 | ||
Rock Springs Capital Management | 325k | $13M | 100% | Dec 2020 | ||
BlackRock | 310k | $12M | 100% | Dec 2020 | ||
Novo A/S | 300k | $12M | 100% | Dec 2020 | ||
Woodline Partners | 277k | $11M | 100% | Dec 2020 | ||
Farallon Capital Management | 250k | $9.9M | 100% | Dec 2020 | ||
Federated Investors | 250k | $9.9M | 100% | Dec 2020 | ||
Franklin Resources | 175k | $7.0M | 100% | Dec 2020 | ||
Eventide Asset Management | 175k | $7.0M | 100% | Dec 2020 | ||
Invesco | 167k | $6.7M | 100% | Dec 2020 | ||
Artal Group | 125k | $5.0M | 100% | Dec 2020 | ||
Victory Capital Management | 107k | $4.2M | 100% | Dec 2020 | ||
Millennium Management | 90k | $3.6M | 100% | Dec 2020 | ||
DAFNA Capital Management | 68k | $2.7M | 100% | Dec 2020 | ||
Goldman Sachs Group | 60k | $2.4M | 100% | Dec 2020 | ||
Tudor Investment Corporation | 40k | $1.6M | 100% | Dec 2020 | ||
UBS Group | 40k | $1.6M | 100% | Dec 2020 | ||
TD Asset Management | 38k | $1.5M | 100% | Dec 2020 | ||
Geode Capital Management | 30k | $1.2M | 100% | Dec 2020 | ||
Pinz Capital Management | 26k | $1.0M | 100% | Dec 2020 | ||
Norges Bank Investment Management | 25k | $995k | 100% | Dec 2020 | ||
EcoR1 Capital | 25k | $995k | 100% | Dec 2020 | ||
ExodusPoint Capital Management | 21k | $835k | 100% | Dec 2020 | ||
Citigroup | 15k | $607k | 100% | Dec 2020 | ||
Ensign Peak Advisors | 15k | $597k | 100% | Dec 2020 | ||
Tibra Equities Europe | 13k | $533k | 100% | Dec 2020 | ||
SG Americas Securities | 13k | $533k | 100% | Dec 2020 | ||
Mirabella Financial Services | 10k | $412k | 100% | Dec 2020 | ||
American Century Companies | 7.1k | $284k | 100% | Dec 2020 | ||
Qube Research & Technologies | 6.1k | $242k | 100% | Dec 2020 | ||
Jane Street | 6.0k | $241k | 100% | Dec 2020 | ||
Maven Securities | 6.0k | $237k | 100% | Dec 2020 | ||
Wellington Management Company | 5.7k | $227k | 100% | Dec 2020 | ||
Hrt Financial | 5.6k | $223k | 100% | Dec 2020 | ||
S.A.C. Capital Advisors | 5.5k | $217k | 100% | Dec 2020 | ||
Rockefeller Capital Management | 3.3k | $129k | 100% | Dec 2020 | ||
Ikarian Capital | 2.0k | $79k | 100% | Dec 2020 | ||
Royal Bank of Canada | 500.00 | $20k | 100% | Dec 2020 | ||
Pathstone Family Office | 198.00 | $8.0k | 100% | Dec 2020 |